CNBC Squawk Box April 22, 2014
Immediately. A lot of moving parts here. It is completely overhauling and remaking this company. It just depends on which businesses fit in with the ones you have and how you want to position yourself for the future. Were talking to lickliter, arent we . We are. From eli lilly. Novartis is up 1. 25 in reaction to the news, Glaxo Smithkline is up by more than 4. 5 and eli lilly up by 0. 5 . A couple programming notes for glaxos ceo, sir andrew witty will be here. At 7 15 eastern time as joe just mentioned, we have an exclusive interview with eli lillys chief John Lechleiter. When there were rum...